Unither Pharmaceuticals
4 clinical trials · Sponsor
◉ Watch Unither Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment (NCT00086632) | Unither Pharmaceuticals | 2004-07-01 |
| Clinical Trial for Ovarian Cancer (OvaRex®) (NCT00050375) | Unither Pharmaceuticals | 2002-12-01 |
| A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma (NCT00034138) | Unither Pharmaceuticals | 2002-03-01 |
| Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma (NCT00034372) | Unither Pharmaceuticals | 2000-09-01 |
Track Unither Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.